Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
8233 ARTÍCULOS , VIENDO DEL 3316 AL 3330
Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease
Liyanage SI, Vilekar P, Weaver DF.
Can J Neurol Sci. 2019 Jan;46(1):23-34. doi: 10.1017/cjn.2018.353.
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
Cummings JL, Tong G, Ballard C.
J Alzheimers Dis. 2019;67(3):779-794. doi: 10.3233/JAD-180766.
The P2X7 receptor: a new therapeutic target in Alzheimer's disease
Illes P, Rubini P, Huang L, Tang Y.
Expert Opin Ther Targets. 2019 Mar;23(3):165-176. doi: 10.1080/14728222.2019.1575811.
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer's disease
Tiozzo Fasiolo L, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, Colombo P, Valsami G, Colombo G, Russo P.
J Drug Target. 2019 Nov;27(9):984-994. doi: 10.1080/1061186X.2019.1574300. Epub 2019 Feb 11.
Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y, Li X, Cheng J, Hou L.
Int J Mol Sci. 2019 Jan 28;20(3):558. doi: 10.3390/ijms20030558.
Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors
Saxena M, Dubey R.
Curr Top Med Chem. 2019;19(4):264-275. doi: 10.2174/1568026619666190128125912.
Facts, Results, and Perspectives of the Current Alzheimer's Disease Research
Marco-Contelles J.
ACS Chem Neurosci. 2019 Mar 20;10(3):1127-1128. doi: 10.1021/acschemneuro.9b00034. Epub 2019 Feb 1.
New evolutions in the BACE1 inhibitor field from 2014 to 2018
Hsiao CC, Rombouts F, Gijsen HJM.
Bioorg Med Chem Lett. 2019 Mar 15;29(6):761-777. doi: 10.1016/j.bmcl.2018.12.049. Epub 2019 Jan 4.
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Nalivaeva NN, Turner AJ.
Br J Pharmacol. 2019 Sep;176(18):3447-3463. doi: 10.1111/bph.14593. Epub 2019 Mar 11.
Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine
Zeng Q, Siu W, Li L, Jin Y, Liang S, Cao M, Ma M, Wu Z.
Exp Gerontol. 2019 May;119:100-110. doi: 10.1016/j.exger.2019.01.027. Epub 2019 Jan 30.
Small Molecule Natural Products and Alzheimer's Disease
Wu X, Cai H, Pan L, Cui G, Qin F, Li Y, Cai Z.
Curr Top Med Chem. 2019;19(3):187-204. doi: 10.2174/1568026619666190201153257.
Important advances in Alzheimer's disease from the use of induced pluripotent stem cells
Majolo F, Marinowic DR, Machado DC, Da Costa JC.
J Biomed Sci. 2019 Feb 6;26(1):15. doi: 10.1186/s12929-019-0501-5.
Jojo GM, Kuppusamy G.
J Clin Pharm Ther. 2019 Jun;44(3):337-348. doi: 10.1111/jcpt.12808. Epub 2019 Feb 9.
Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines
de Los Ríos C, Marco-Contelles J.
Eur J Med Chem. 2019 Mar 15;166:381-389. doi: 10.1016/j.ejmech.2019.02.005. Epub 2019 Feb 4.
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E.
Br J Pharmacol. 2019 Sep;176(18):3515-3532. doi: 10.1111/bph.14618. Epub 2019 May 11.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.